The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Heparin (Heparin Sodium and Heparin Calcium) Market Research Report 2024
Synopsis
Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine.
Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
This report is revolving around Heparin Active Pharmaceutical Ingredients (API).
The global Heparin (Heparin Sodium and Heparin Calcium) market was valued at US$ 2632.1 million in 2023 and is anticipated to reach US$ 6113.5 million by 2030, witnessing a CAGR of 12.5% during the forecast period 2024-2030.
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
The market driver mainly increasing prevalence of conditions such as renal impairment, coronary artery disease, and venous thromboembolism, High demand for anticoagulants, etc.
In recent years, with the impact of African swine fever and the outbreak of COVID-19. Heparin as a resource-based industry expected to be in a state of tight supply for a period in the future, and the tight supply state may drive the sales price of heparin products to rise, the future driving force of the industry is more obvious, and the long-term profitability is more certain. The price of heparin has ushered in a major upward cycle since 2016. The main reason is that China is the main supplier of live pigs in the world. The raging African swine fever has greatly reduced the supply of live pigs, driving the price of heparin to rise sharply.
Asia-Pacific is the largest consumption place, with a revenue market share nearly 35% in 2022. Mainly China is the worlds’ largest pig production, which supplied by sufficient raw materials. Following Asia-Pacific, Europe is the second largest consumption place with the revenue market share nearly 34%.
The global key manufacturers of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, Bioibérica, Qingdao Jiulong Biopharmaceutical, Changzhou Qianhong Biopharma, and etc. In 2022, the global top five players hold a share approximately 57% in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Heparin (Heparin Sodium and Heparin Calcium), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin (Heparin Sodium and Heparin Calcium).
Report Scope
The Heparin (Heparin Sodium and Heparin Calcium) market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Heparin (Heparin Sodium and Heparin Calcium) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heparin (Heparin Sodium and Heparin Calcium) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Nanjing King-friend Biochemical Pharmaceutical
Pfizer
Hebei Changshan Biochemical Pharmaceutical
Bioibérica
Qingdao Jiulong Biopharmaceutical
Changzhou Qianhong Biopharma
Dongying Tiandong Pharmaceutical
Opocrin
Hubei Enoray Biopharmaceutical
Yino Pharma
Cisen Pharmaceutical
Nanjing Xinbai Pharmaceutical
Sichuan Deebio Pharmaceutical
Segment by Type
Heparin Sodium
Heparin Calcium
Segment by Application
UFH
LMWH
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Heparin (Heparin Sodium and Heparin Calcium) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Heparin (Heparin Sodium and Heparin Calcium) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine.
Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
This report is revolving around Heparin Active Pharmaceutical Ingredients (API).
The global Heparin (Heparin Sodium and Heparin Calcium) market was valued at US$ 2632.1 million in 2023 and is anticipated to reach US$ 6113.5 million by 2030, witnessing a CAGR of 12.5% during the forecast period 2024-2030.
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
The market driver mainly increasing prevalence of conditions such as renal impairment, coronary artery disease, and venous thromboembolism, High demand for anticoagulants, etc.
In recent years, with the impact of African swine fever and the outbreak of COVID-19. Heparin as a resource-based industry expected to be in a state of tight supply for a period in the future, and the tight supply state may drive the sales price of heparin products to rise, the future driving force of the industry is more obvious, and the long-term profitability is more certain. The price of heparin has ushered in a major upward cycle since 2016. The main reason is that China is the main supplier of live pigs in the world. The raging African swine fever has greatly reduced the supply of live pigs, driving the price of heparin to rise sharply.
Asia-Pacific is the largest consumption place, with a revenue market share nearly 35% in 2022. Mainly China is the worlds’ largest pig production, which supplied by sufficient raw materials. Following Asia-Pacific, Europe is the second largest consumption place with the revenue market share nearly 34%.
The global key manufacturers of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, Bioibérica, Qingdao Jiulong Biopharmaceutical, Changzhou Qianhong Biopharma, and etc. In 2022, the global top five players hold a share approximately 57% in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Heparin (Heparin Sodium and Heparin Calcium), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin (Heparin Sodium and Heparin Calcium).
Report Scope
The Heparin (Heparin Sodium and Heparin Calcium) market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Heparin (Heparin Sodium and Heparin Calcium) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heparin (Heparin Sodium and Heparin Calcium) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Nanjing King-friend Biochemical Pharmaceutical
Pfizer
Hebei Changshan Biochemical Pharmaceutical
Bioibérica
Qingdao Jiulong Biopharmaceutical
Changzhou Qianhong Biopharma
Dongying Tiandong Pharmaceutical
Opocrin
Hubei Enoray Biopharmaceutical
Yino Pharma
Cisen Pharmaceutical
Nanjing Xinbai Pharmaceutical
Sichuan Deebio Pharmaceutical
Segment by Type
Heparin Sodium
Heparin Calcium
Segment by Application
UFH
LMWH
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Heparin (Heparin Sodium and Heparin Calcium) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Heparin (Heparin Sodium and Heparin Calcium) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Heparin (Heparin Sodium and Heparin Calcium) Market Overview
1.1 Product Overview and Scope of Heparin (Heparin Sodium and Heparin Calcium)
1.2 Heparin (Heparin Sodium and Heparin Calcium) Segment by Type
1.2.1 Global Heparin (Heparin Sodium and Heparin Calcium) Market Value Comparison by Type (2024-2030)
1.2.2 Heparin Sodium
1.2.3 Heparin Calcium
1.3 Heparin (Heparin Sodium and Heparin Calcium) Segment by Application
1.3.1 Global Heparin (Heparin Sodium and Heparin Calcium) Market Value by Application: (2024-2030)
1.3.2 UFH
1.3.3 LMWH
1.4 Global Heparin (Heparin Sodium and Heparin Calcium) Market Size Estimates and Forecasts
1.4.1 Global Heparin (Heparin Sodium and Heparin Calcium) Revenue 2019-2030
1.4.2 Global Heparin (Heparin Sodium and Heparin Calcium) Sales 2019-2030
1.4.3 Global Heparin (Heparin Sodium and Heparin Calcium) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Heparin (Heparin Sodium and Heparin Calcium) Market Competition by Manufacturers
2.1 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Heparin (Heparin Sodium and Heparin Calcium) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Heparin (Heparin Sodium and Heparin Calcium) Average Price by Manufacturers (2019-2024)
2.4 Global Heparin (Heparin Sodium and Heparin Calcium) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Heparin (Heparin Sodium and Heparin Calcium), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Heparin (Heparin Sodium and Heparin Calcium), Product Type & Application
2.7 Heparin (Heparin Sodium and Heparin Calcium) Market Competitive Situation and Trends
2.7.1 Heparin (Heparin Sodium and Heparin Calcium) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Heparin (Heparin Sodium and Heparin Calcium) Players Market Share by Revenue
2.7.3 Global Heparin (Heparin Sodium and Heparin Calcium) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Heparin (Heparin Sodium and Heparin Calcium) Retrospective Market Scenario by Region
3.1 Global Heparin (Heparin Sodium and Heparin Calcium) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Heparin (Heparin Sodium and Heparin Calcium) Global Heparin (Heparin Sodium and Heparin Calcium) Sales by Region: 2019-2030
3.2.1 Global Heparin (Heparin Sodium and Heparin Calcium) Sales by Region: 2019-2024
3.2.2 Global Heparin (Heparin Sodium and Heparin Calcium) Sales by Region: 2025-2030
3.3 Global Heparin (Heparin Sodium and Heparin Calcium) Global Heparin (Heparin Sodium and Heparin Calcium) Revenue by Region: 2019-2030
3.3.1 Global Heparin (Heparin Sodium and Heparin Calcium) Revenue by Region: 2019-2024
3.3.2 Global Heparin (Heparin Sodium and Heparin Calcium) Revenue by Region: 2025-2030
3.4 North America Heparin (Heparin Sodium and Heparin Calcium) Market Facts & Figures by Country
3.4.1 North America Heparin (Heparin Sodium and Heparin Calcium) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Heparin (Heparin Sodium and Heparin Calcium) Sales by Country (2019-2030)
3.4.3 North America Heparin (Heparin Sodium and Heparin Calcium) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Heparin (Heparin Sodium and Heparin Calcium) Market Facts & Figures by Country
3.5.1 Europe Heparin (Heparin Sodium and Heparin Calcium) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Heparin (Heparin Sodium and Heparin Calcium) Sales by Country (2019-2030)
3.5.3 Europe Heparin (Heparin Sodium and Heparin Calcium) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Heparin (Heparin Sodium and Heparin Calcium) Market Facts & Figures by Country
3.6.1 Asia Pacific Heparin (Heparin Sodium and Heparin Calcium) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Heparin (Heparin Sodium and Heparin Calcium) Sales by Country (2019-2030)
3.6.3 Asia Pacific Heparin (Heparin Sodium and Heparin Calcium) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Heparin (Heparin Sodium and Heparin Calcium) Market Facts & Figures by Country
3.7.1 Latin America Heparin (Heparin Sodium and Heparin Calcium) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Heparin (Heparin Sodium and Heparin Calcium) Sales by Country (2019-2030)
3.7.3 Latin America Heparin (Heparin Sodium and Heparin Calcium) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Heparin (Heparin Sodium and Heparin Calcium) Market Facts & Figures by Country
3.8.1 Middle East and Africa Heparin (Heparin Sodium and Heparin Calcium) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Heparin (Heparin Sodium and Heparin Calcium) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Heparin (Heparin Sodium and Heparin Calcium) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Heparin (Heparin Sodium and Heparin Calcium) Sales by Type (2019-2030)
4.1.1 Global Heparin (Heparin Sodium and Heparin Calcium) Sales by Type (2019-2024)
4.1.2 Global Heparin (Heparin Sodium and Heparin Calcium) Sales by Type (2025-2030)
4.1.3 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Market Share by Type (2019-2030)
4.2 Global Heparin (Heparin Sodium and Heparin Calcium) Revenue by Type (2019-2030)
4.2.1 Global Heparin (Heparin Sodium and Heparin Calcium) Revenue by Type (2019-2024)
4.2.2 Global Heparin (Heparin Sodium and Heparin Calcium) Revenue by Type (2025-2030)
4.2.3 Global Heparin (Heparin Sodium and Heparin Calcium) Revenue Market Share by Type (2019-2030)
4.3 Global Heparin (Heparin Sodium and Heparin Calcium) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Heparin (Heparin Sodium and Heparin Calcium) Sales by Application (2019-2030)
5.1.1 Global Heparin (Heparin Sodium and Heparin Calcium) Sales by Application (2019-2024)
5.1.2 Global Heparin (Heparin Sodium and Heparin Calcium) Sales by Application (2025-2030)
5.1.3 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Market Share by Application (2019-2030)
5.2 Global Heparin (Heparin Sodium and Heparin Calcium) Revenue by Application (2019-2030)
5.2.1 Global Heparin (Heparin Sodium and Heparin Calcium) Revenue by Application (2019-2024)
5.2.2 Global Heparin (Heparin Sodium and Heparin Calcium) Revenue by Application (2025-2030)
5.2.3 Global Heparin (Heparin Sodium and Heparin Calcium) Revenue Market Share by Application (2019-2030)
5.3 Global Heparin (Heparin Sodium and Heparin Calcium) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Shenzhen Hepalink Pharmaceutical
6.1.1 Shenzhen Hepalink Pharmaceutical Corporation Information
6.1.2 Shenzhen Hepalink Pharmaceutical Description and Business Overview
6.1.3 Shenzhen Hepalink Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Shenzhen Hepalink Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Portfolio
6.1.5 Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
6.2 Yantai Dongcheng Pharmaceutical
6.2.1 Yantai Dongcheng Pharmaceutical Corporation Information
6.2.2 Yantai Dongcheng Pharmaceutical Description and Business Overview
6.2.3 Yantai Dongcheng Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Yantai Dongcheng Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Portfolio
6.2.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates
6.3 Nanjing King-friend Biochemical Pharmaceutical
6.3.1 Nanjing King-friend Biochemical Pharmaceutical Corporation Information
6.3.2 Nanjing King-friend Biochemical Pharmaceutical Description and Business Overview
6.3.3 Nanjing King-friend Biochemical Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Nanjing King-friend Biochemical Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Portfolio
6.3.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Heparin (Heparin Sodium and Heparin Calcium) Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Hebei Changshan Biochemical Pharmaceutical
6.5.1 Hebei Changshan Biochemical Pharmaceutical Corporation Information
6.5.2 Hebei Changshan Biochemical Pharmaceutical Description and Business Overview
6.5.3 Hebei Changshan Biochemical Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hebei Changshan Biochemical Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Portfolio
6.5.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
6.6 Bioibérica
6.6.1 Bioibérica Corporation Information
6.6.2 Bioibérica Description and Business Overview
6.6.3 Bioibérica Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bioibérica Heparin (Heparin Sodium and Heparin Calcium) Product Portfolio
6.6.5 Bioibérica Recent Developments/Updates
6.7 Qingdao Jiulong Biopharmaceutical
6.6.1 Qingdao Jiulong Biopharmaceutical Corporation Information
6.6.2 Qingdao Jiulong Biopharmaceutical Description and Business Overview
6.6.3 Qingdao Jiulong Biopharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Qingdao Jiulong Biopharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Portfolio
6.7.5 Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
6.8 Changzhou Qianhong Biopharma
6.8.1 Changzhou Qianhong Biopharma Corporation Information
6.8.2 Changzhou Qianhong Biopharma Description and Business Overview
6.8.3 Changzhou Qianhong Biopharma Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Changzhou Qianhong Biopharma Heparin (Heparin Sodium and Heparin Calcium) Product Portfolio
6.8.5 Changzhou Qianhong Biopharma Recent Developments/Updates
6.9 Dongying Tiandong Pharmaceutical
6.9.1 Dongying Tiandong Pharmaceutical Corporation Information
6.9.2 Dongying Tiandong Pharmaceutical Description and Business Overview
6.9.3 Dongying Tiandong Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Dongying Tiandong Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Portfolio
6.9.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
6.10 Opocrin
6.10.1 Opocrin Corporation Information
6.10.2 Opocrin Description and Business Overview
6.10.3 Opocrin Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Opocrin Heparin (Heparin Sodium and Heparin Calcium) Product Portfolio
6.10.5 Opocrin Recent Developments/Updates
6.11 Hubei Enoray Biopharmaceutical
6.11.1 Hubei Enoray Biopharmaceutical Corporation Information
6.11.2 Hubei Enoray Biopharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Description and Business Overview
6.11.3 Hubei Enoray Biopharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hubei Enoray Biopharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Portfolio
6.11.5 Hubei Enoray Biopharmaceutical Recent Developments/Updates
6.12 Yino Pharma
6.12.1 Yino Pharma Corporation Information
6.12.2 Yino Pharma Heparin (Heparin Sodium and Heparin Calcium) Description and Business Overview
6.12.3 Yino Pharma Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Yino Pharma Heparin (Heparin Sodium and Heparin Calcium) Product Portfolio
6.12.5 Yino Pharma Recent Developments/Updates
6.13 Cisen Pharmaceutical
6.13.1 Cisen Pharmaceutical Corporation Information
6.13.2 Cisen Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Description and Business Overview
6.13.3 Cisen Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Cisen Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Portfolio
6.13.5 Cisen Pharmaceutical Recent Developments/Updates
6.14 Nanjing Xinbai Pharmaceutical
6.14.1 Nanjing Xinbai Pharmaceutical Corporation Information
6.14.2 Nanjing Xinbai Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Description and Business Overview
6.14.3 Nanjing Xinbai Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Nanjing Xinbai Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Portfolio
6.14.5 Nanjing Xinbai Pharmaceutical Recent Developments/Updates
6.15 Sichuan Deebio Pharmaceutical
6.15.1 Sichuan Deebio Pharmaceutical Corporation Information
6.15.2 Sichuan Deebio Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Description and Business Overview
6.15.3 Sichuan Deebio Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Sichuan Deebio Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Portfolio
6.15.5 Sichuan Deebio Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Heparin (Heparin Sodium and Heparin Calcium) Industry Chain Analysis
7.2 Heparin (Heparin Sodium and Heparin Calcium) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Heparin (Heparin Sodium and Heparin Calcium) Production Mode & Process
7.4 Heparin (Heparin Sodium and Heparin Calcium) Sales and Marketing
7.4.1 Heparin (Heparin Sodium and Heparin Calcium) Sales Channels
7.4.2 Heparin (Heparin Sodium and Heparin Calcium) Distributors
7.5 Heparin (Heparin Sodium and Heparin Calcium) Customers
8 Heparin (Heparin Sodium and Heparin Calcium) Market Dynamics
8.1 Heparin (Heparin Sodium and Heparin Calcium) Industry Trends
8.2 Heparin (Heparin Sodium and Heparin Calcium) Market Drivers
8.3 Heparin (Heparin Sodium and Heparin Calcium) Market Challenges
8.4 Heparin (Heparin Sodium and Heparin Calcium) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
